Sphera Funds Management’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-44,841
| Closed | -$1.78M | – | 138 |
|
|
2024
Q1 | $1.78M | Sell |
44,841
-190,000
| -81% | -$5.61M | 0.25% | 82 |
|
|
2023
Q4 | $4.48M | Buy |
234,841
+54,841
| +30% | +$762K | 0.72% | 53 |
|
|
2023
Q3 | $2.06M | Sell |
180,000
-20,000
| -10% | -$246K | 0.38% | 66 |
|
|
2023
Q2 | $2.06M | Hold |
200,000
| – | – | 0.32% | 71 |
|
|
2023
Q1 | $1.54M | Hold |
200,000
| – | – | 0.26% | 64 |
|
|
2022
Q4 | $1.47M | Hold |
200,000
| – | – | 0.32% | 47 |
|
|
2022
Q3 | $1.44M | Buy |
+200,000
| New | +$1.65M | 0.2% | 58 |
|
|
2021
Q2 | – | Sell |
-198,260
| Closed | -$2.1M | – | 174 |
|
|
2021
Q1 | $2.1M | Hold |
198,260
| – | – | 0.16% | 108 |
|
|
2020
Q4 | $2.5M | Hold |
198,260
| – | – | 0.22% | 82 |
|
|
2020
Q3 | $1.74M | Buy |
+198,260
| New | +$1.81M | 0.17% | 79 |
|
|
2016
Q4 | – | Sell |
-51,175
| Closed | -$1.66M | – | 121 |
|
|
2016
Q3 | $1.66M | Buy |
+51,175
| New | +$1.25M | 0.27% | 80 |
|
|
2016
Q2 | – | Sell |
-19,975
| Closed | -$333K | – | 114 |
|
|
2016
Q1 | $333K | Sell |
19,975
-37,912
| -65% | -$759K | 0.07% | 86 |
|
|
2015
Q4 | $1.79M | Buy |
57,887
+7,457
| +15% | +$255K | 0.26% | 91 |
|
|
2015
Q3 | $2.62M | Sell |
50,430
-13,320
| -21% | -$875K | 0.33% | 73 |
|
|
2015
Q2 | $3.86M | Buy |
+63,750
| New | +$3.8M | 0.38% | 63 |
|
Sphera Funds Management's ALPN Position: Q2 2024 in Review
Sphera Funds Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 44,841 shares — an estimated $1.78M sold.
Sphera Funds Management first reported a position in ALPN in Q2 2015 and held it in 15 quarters. The position peaked at $4.48M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Sphera Funds Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Sphera Funds Management sold 44,841 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.78M.
- Sphera Funds Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 15 quarters.
- Sphera Funds Management's Alpine Immune Sciences Inc position peaked at $4.48M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Sphera Funds Management's 13F filing for Q2 2024, filed 14 Aug 2024.